Camelus dromedarius (Arabian camel): 105093155
Help
Entry
105093155 CDS
T04642
Symbol
IL1B
Name
(RefSeq) interleukin-1 beta
KO
K04519
interleukin 1 beta
Organism
cdk
Camelus dromedarius (Arabian camel)
Pathway
cdk01523
Antifolate resistance
cdk04010
MAPK signaling pathway
cdk04060
Cytokine-cytokine receptor interaction
cdk04064
NF-kappa B signaling pathway
cdk04217
Necroptosis
cdk04380
Osteoclast differentiation
cdk04620
Toll-like receptor signaling pathway
cdk04621
NOD-like receptor signaling pathway
cdk04623
Cytosolic DNA-sensing pathway
cdk04625
C-type lectin receptor signaling pathway
cdk04640
Hematopoietic cell lineage
cdk04657
IL-17 signaling pathway
cdk04659
Th17 cell differentiation
cdk04668
TNF signaling pathway
cdk04750
Inflammatory mediator regulation of TRP channels
cdk04932
Non-alcoholic fatty liver disease
cdk04933
AGE-RAGE signaling pathway in diabetic complications
cdk04936
Alcoholic liver disease
cdk04940
Type I diabetes mellitus
cdk05010
Alzheimer disease
cdk05020
Prion disease
cdk05022
Pathways of neurodegeneration - multiple diseases
cdk05132
Salmonella infection
cdk05133
Pertussis
cdk05134
Legionellosis
cdk05135
Yersinia infection
cdk05140
Leishmaniasis
cdk05142
Chagas disease
cdk05143
African trypanosomiasis
cdk05144
Malaria
cdk05146
Amoebiasis
cdk05152
Tuberculosis
cdk05162
Measles
cdk05163
Human cytomegalovirus infection
cdk05164
Influenza A
cdk05168
Herpes simplex virus 1 infection
cdk05171
Coronavirus disease - COVID-19
cdk05321
Inflammatory bowel disease
cdk05323
Rheumatoid arthritis
cdk05332
Graft-versus-host disease
cdk05417
Lipid and atherosclerosis
cdk05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
cdk00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
105093155 (IL1B)
04064 NF-kappa B signaling pathway
105093155 (IL1B)
04668 TNF signaling pathway
105093155 (IL1B)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
105093155 (IL1B)
09140 Cellular Processes
09143 Cell growth and death
04217 Necroptosis
105093155 (IL1B)
09150 Organismal Systems
09151 Immune system
04640 Hematopoietic cell lineage
105093155 (IL1B)
04620 Toll-like receptor signaling pathway
105093155 (IL1B)
04621 NOD-like receptor signaling pathway
105093155 (IL1B)
04623 Cytosolic DNA-sensing pathway
105093155 (IL1B)
04625 C-type lectin receptor signaling pathway
105093155 (IL1B)
04659 Th17 cell differentiation
105093155 (IL1B)
04657 IL-17 signaling pathway
105093155 (IL1B)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
105093155 (IL1B)
09158 Development and regeneration
04380 Osteoclast differentiation
105093155 (IL1B)
09160 Human Diseases
09172 Infectious disease: viral
05171 Coronavirus disease - COVID-19
105093155 (IL1B)
05164 Influenza A
105093155 (IL1B)
05162 Measles
105093155 (IL1B)
05168 Herpes simplex virus 1 infection
105093155 (IL1B)
05163 Human cytomegalovirus infection
105093155 (IL1B)
09171 Infectious disease: bacterial
05132 Salmonella infection
105093155 (IL1B)
05135 Yersinia infection
105093155 (IL1B)
05133 Pertussis
105093155 (IL1B)
05134 Legionellosis
105093155 (IL1B)
05152 Tuberculosis
105093155 (IL1B)
09174 Infectious disease: parasitic
05146 Amoebiasis
105093155 (IL1B)
05144 Malaria
105093155 (IL1B)
05140 Leishmaniasis
105093155 (IL1B)
05142 Chagas disease
105093155 (IL1B)
05143 African trypanosomiasis
105093155 (IL1B)
09163 Immune disease
05323 Rheumatoid arthritis
105093155 (IL1B)
05321 Inflammatory bowel disease
105093155 (IL1B)
05332 Graft-versus-host disease
105093155 (IL1B)
09164 Neurodegenerative disease
05010 Alzheimer disease
105093155 (IL1B)
05020 Prion disease
105093155 (IL1B)
05022 Pathways of neurodegeneration - multiple diseases
105093155 (IL1B)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
105093155 (IL1B)
05418 Fluid shear stress and atherosclerosis
105093155 (IL1B)
09167 Endocrine and metabolic disease
04940 Type I diabetes mellitus
105093155 (IL1B)
04936 Alcoholic liver disease
105093155 (IL1B)
04932 Non-alcoholic fatty liver disease
105093155 (IL1B)
04933 AGE-RAGE signaling pathway in diabetic complications
105093155 (IL1B)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
105093155 (IL1B)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:
cdk04052
]
105093155 (IL1B)
00536 Glycosaminoglycan binding proteins [BR:
cdk00536
]
105093155 (IL1B)
Cytokines and neuropeptides [BR:
cdk04052
]
Cytokines
Interleukins
105093155 (IL1B)
Glycosaminoglycan binding proteins [BR:
cdk00536
]
Heparan sulfate / Heparin
Cytokines
105093155 (IL1B)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
IL1
IL1_propep
Motif
Other DBs
NCBI-GeneID:
105093155
NCBI-ProteinID:
XP_010983296
LinkDB
All DBs
Position
28:complement(8843505..8850727)
Genome browser
AA seq
267 aa
AA seq
DB search
MAAVPEPASEMMAYYSDNDNDLLFEADGPKQMKCCVQPLDLGSLGDEGIKLQISHQLYNK
SFRQVVSVIVAMEKLSKCPYSQYFQDDDLRNIFSLIFEEEPVTFETCTDDFVCDAAVQSL
YCKLQDKEQKSLVLASPCVLQALHLLAQDMSREVVFCMSFVQGDESNSKIPVVLGLKEKN
LYLSCVMKGDKPTLQLEALDPKSYPRRNMEKRFVFYKTEIKDRVEFESALYPNWYISTST
AEQRPVFLGQSRGGQDITDFTMEIVSP
NT seq
804 nt
NT seq
+upstream
nt +downstream
nt
atggcagcagtacctgaacccgccagtgaaatgatggcttactacagtgacaatgacaat
gacctgttatttgaagctgatggccccaaacagatgaagtgctgcgtccaacccctggac
ctcggctctctgggagatgaggggatcaagctgcagatctcccaccagctctacaacaag
agcttcaggcaggtggtgtcggtcatcgtggccatggagaagctgagcaagtgtccctac
tcacagtacttccaggatgatgacctgaggaacatcttttcgctcatctttgaagaagag
cctgtcacctttgaaacgtgcactgatgatttcgtgtgcgacgcggccgtgcagtcgctg
tactgcaaactccaggacaaagagcagaagtccctggtgctggctagcccgtgtgtgctg
caggctctccacctcctcgcacaggatatgagccgagaagtggtgttctgcatgagcttt
gtgcaaggggacgaaagcaacagcaagatacctgtggtcttgggcctcaaggagaagaat
ctatacctgtcttgtgtgatgaaaggggataagcccaccctgcagctggaggcactggac
cccaaaagttatccaaggaggaacatggaaaagcgatttgtcttctacaagacagaaatc
aaggatagggtggaatttgagtctgccctgtatcccaactggtacatcagcacctctaca
gctgaacaaagacccgtcttcctaggacagtccagaggaggccaggatataactgacttc
accatggaaatcgtctctccctaa
DBGET
integrated database retrieval system